MYR 0.36
(0.0%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | 249.48 Million | 321.16 Million | 187 Million | 154.9 Million | 63.3 Million |
Net Income | - | - | - | - | - | - |
Depreciation & Amortization | - | - | - | - | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | - | - | - | - |
Other non-cash items | - | - | - | - | - | - |
Investing Cash Flow | -51.57 Million | -74.38 Million | -116.26 Million | -48.31 Million | -55.66 Million | -49.46 Million |
Investments in PPE | -53.34 Million | -96.72 Million | -68.24 Million | -48.64 Million | -56.05 Million | -49.97 Million |
Acquisitions | -3.71 Million | -5 Million | -170 Thousand | -170 Thousand | - | - |
Investment purchases | - | -31.97 Million | -26.13 Million | - | - | - |
Sales/Maturities of investments | 2.66 Million | 35.48 Million | 649 Thousand | - | - | - |
Other Investing Activities | -2.95 Million | 23.81 Million | -22.36 Million | 507 Thousand | 396 Thousand | 501 Thousand |
Financing Cash Flow | -54.5 Million | -168.99 Million | -190.04 Million | -138.7 Million | -94.62 Million | -6.16 Million |
Debt repayment | -59.58 Million | -124.5 Million | -167.87 Million | -118.37 Million | -114.26 Million | -184.51 Million |
Dividends payments | -8.77 Million | -59.7 Million | -16.21 Million | -7.1 Million | -10.68 Million | -15.03 Million |
Common Stock Repurchased | - | -39.89 Million | -4.97 Million | -7.13 Million | -7.13 Million | 190.13 Million |
Common Stock Issuance | - | 55.45 Million | 8.2 Million | 2.35 Million | 85 Thousand | 1.98 Million |
Other Financing Activities | -105.32 Million | 55.1 Million | -9.18 Million | -8.44 Million | 37.36 Million | 1.27 Million |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | - | - | - | - |
Cash at beginning of period | 50.07 Million | 42.94 Million | 18.68 Million | 18.65 Million | 14.02 Million | 21.25 Million |
Cash at end of period | 25.08 Million | 50.07 Million | 33.74 Million | 18.68 Million | 18.65 Million | 28.78 Million |
Capital Expenditure | -53.34 Million | -96.72 Million | -68.24 Million | -48.64 Million | -56.05 Million | -49.97 Million |
Effect of forex changes on cash | -92 Thousand | 1.03 Million | 192 Thousand | 28 Thousand | 20 Thousand | -144 Thousand |
Net cash flow / Change in cash | -24.99 Million | 7.13 Million | 15.05 Million | 26 Thousand | 4.63 Million | 7.52 Million |
Free Cash Flow | -53.34 Million | 152.76 Million | 252.92 Million | 138.36 Million | 98.84 Million | 13.33 Million |
Breakdown | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | - | - | - | - | - | - |
Depreciation & Amortization | - | - | - | - | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | - | - | - | - |
Other non-cash items | - | - | - | - | - | - |
Investing Cash Flow | -3.52 Million | -16.27 Million | -15.39 Million | -16.36 Million | -37.19 Million | -74.38 Million |
Investments in PPE | -7.29 Million | -15.79 Million | -18.77 Million | -11.47 Million | -46.33 Million | -96.72 Million |
Acquisitions | 1.33 Million | -1.96 Million | 1.91 Million | -5 Million | - | -5 Million |
Investment purchases | - | - | 1.7 Million | - | - | -31.97 Million |
Sales/Maturities of investments | - | 1.3 Million | 1.35 Million | - | 8.06 Million | 35.48 Million |
Other Investing Activities | 2.34 Million | -279 Thousand | -1.6 Million | 104 Thousand | 1.07 Million | 23.81 Million |
Financing Cash Flow | 17.78 Million | -27.98 Million | -5.61 Million | -38.69 Million | -842 Thousand | -168.99 Million |
Debt repayment | -47.09 Million | -5.36 Million | -20.06 Million | -62.86 Million | -500 Thousand | -124.5 Million |
Dividends payments | - | - | - | -8.77 Million | -8.77 Million | -59.7 Million |
Common Stock Repurchased | - | - | - | - | - | -39.89 Million |
Common Stock Issuance | - | - | - | - | - | 55.45 Million |
Other Financing Activities | -29.3 Million | 1000.00 | 48 Thousand | 32.94 Million | 7.42 Million | 55.1 Million |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | - | - | - | - |
Cash at beginning of period | 29.87 Million | 44.61 Million | 45.29 Million | 50.07 Million | 30.42 Million | 42.94 Million |
Cash at end of period | 25.08 Million | 29.87 Million | 44.61 Million | 45.29 Million | 50.07 Million | 50.07 Million |
Capital Expenditure | -7.29 Million | -15.79 Million | -18.77 Million | -11.47 Million | -46.33 Million | -96.72 Million |
Effect of forex changes on cash | -198 Thousand | 146 Thousand | 10 Thousand | -50 Thousand | 510 Thousand | 1.03 Million |
Net cash flow / Change in cash | -4.79 Million | -14.73 Million | -684 Thousand | -4.77 Million | 19.64 Million | 7.13 Million |
Free Cash Flow | -7.29 Million | -15.79 Million | 1.53 Million | 38.86 Million | 10.84 Million | 152.76 Million |
ALDNX
2802
EQIX
NATCOPHARM
DISHTV
4480